Beta Bionics, Inc. (BBNX) Payables (2023 - 2026)

Beta Bionics (BBNX) has 4 years of Payables data on file, last reported at $2.3 million in Q1 2026.

• Quarterly Payables fell 32.89% year-over-year to $2.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.3 million (down 32.89% YoY) and the FY2025 annual result came in at $5.0 million, up 75.25% from the prior year.
• Payables eased to $2.3 million in Q1 2026 per BBNX's latest filing, from $5.0 million in the prior quarter.
• The five-year high for Payables was $5.0 million in Q4 2025, with the low at $1.2 million in Q4 2023.
• Average Payables over 4 years is $3.2 million, with a median of $3.4 million recorded in 2025.
• Year-over-year, Payables surged 144.6% in 2024 and slumped 32.89% in 2026.
• Beta Bionics' Payables stood at $1.2 million in 2023, then jumped by 144.6% to $2.9 million in 2024, then surged by 75.25% to $5.0 million in 2025, then tumbled by 53.62% to $2.3 million in 2026.
• Business Quant data shows BBNX's Payables at $2.3 million in Q1 2026, $5.0 million in Q4 2025, and $4.5 million in Q3 2025.